Table 1.
Clinicopathological parameters | n | Relative USP21 expression | ||
---|---|---|---|---|
Low | High | p Value | ||
Age | 0.612 | |||
≤60 | 26 | 16 | 10 | |
>60 | 16 | 7 | 9 | |
Sex | 0.473 | |||
Male | 31 | 14 | 17 | |
Female | 11 | 6 | 5 | |
Smoker | 0.078 | |||
Yes | 25 | 11 | 14 | |
No | 17 | 10 | 7 | |
Lymph node metastasis | 0.035* | |||
Positive | 14 | 9 | 5 | |
Negative | 28 | 11 | 17 | |
TNM stage | 0.041* | |||
I/II | 26 | 14 | 12 | |
III/IV | 16 | 5 | 11 | |
Tumor differentiation | 0.246 | |||
Well/moderate | 37 | 20 | 17 | |
Poor | 5 | 2 | 3 | |
Histological tumor type | 0.453 | |||
Adenocarcinoma | 21 | 12 | 9 | |
Squamous cell carcinoma | 14 | 6 | 8 | |
Others | 7 | 4 | 3 |
χ2 test. *p < 0.05